Results 261 to 270 of about 439,794 (317)
Some of the next articles are maybe not open access.

The Interleukin‐2 Receptor: A Target for Immunotherapy

Annals of the New York Academy of Sciences, 1992
Immune intervention began almost two centuries ago when Jenner introduced vaccination with cowpox as a means of protecting against smallpox. This form of immune intervention plays a dominant role in the prevention of human disease. Furthermore, immunological approaches including radioimmunoassays, enzyme-linked immunoassays, microfluorometry, and ...
THOMAS A. WALDMANN   +21 more
openaire   +3 more sources

Expression of interleukin 2 and the interleukin 2 receptor in aging rats

Cellular Immunology, 1989
Lymphocytes of aged animals exhibit a marked decrease in proliferative capacity in response to mitogen stimulation when compared to those of younger animals. In humans and mice the decreased proliferation is due at least in part (i) to the inability of lymphocytes to synthesize sufficient interleukin 2 (IL-2) and (ii) to decreased expression of IL-2 ...
N J, Holbrook   +6 more
openaire   +2 more sources

Biology of the Interleukin-2 Receptor

1998
Studies of the biology of the IL-2 receptor have played a major part in establishing several of the fundamental principles that govern our current understanding of immunology. Chief among these is the contribution made by lymphokines to regulation of the interactions among vast numbers of lymphocytes, comprising a number of functionally distinct ...
B H, Nelson, D M, Willerford
openaire   +2 more sources

Regulation by interleukin 2 of interleukin 2 receptors and gamma-interferon synthesis by human thymocytes: augmentation of interleukin 2 receptors by interleukin 2.

The Journal of Immunology, 1985
Abstract The role of interleukin 2 (IL 2) on the expression of IL 2 receptors and on the synthesis of gamma-interferon (gamma-IFN) by human thymocytes was investigated. Human thymocytes isolated from specimens obtained during cardiac surgery of infants and children were induced with one or all of the following agents: IL 2, concanavalin ...
G H, Reem, N H, Yeh
openaire   +2 more sources

Interleukin-2, Interleukin-15, and Their Receptors

International Reviews of Immunology, 1998
Both IL-15 and IL-2 are 14-15 kDa members of the four alpha-helical bundle family of cytokines that have T cell growth factor activity. In contrast to the pattern manifested by IL-2, IL-15 mRNA is produced by a wide variety of tissues other than T cells. We have demonstrated that IL-15 expression is posttranscriptionally regulated by multiple elements,
T, Waldmann, Y, Tagaya, R, Bamford
openaire   +2 more sources

Interleukin-2 receptors in infectious mononucleosis

Immunology Letters, 1989
The majority of peripheral blood mononuclear cells (PBMC) from acute-phase infectious mononucleosis (IM) patients express high levels of T10 (CD38) and HLA-DR surface antigens, which are markers characteristic of activated T cells. However, Tac antigen (p55) expression on these cells was not detectable by flow cytometric immunofluorescence, and only a ...
C, Schmidt   +5 more
openaire   +2 more sources

The Interleukin 2 Receptor in the Hypereosinophilic Syndrome

Leukemia & Lymphoma, 1992
The hypereosinophilic syndrome (HES) has been previously described as a clinicobiological entity characterized by a blood eosinophil count of over 1.5 x 10(9)/L of unknown cause associated with several clinical complications. In reality, HES is a heterogeneous group of diseases with variable and unpredictable progress in visceral lesions, thought to be
Plumas, Joël   +4 more
openaire   +3 more sources

Interleukin-2 Receptors

1985
Interleukin-2 (IL-2) is a lymphokine synthesized by some T-cells following activation. Resting T-cells do not express IL-2 receptors but receptors are rapidly expressed on T-cells following the interaction of antigens, mitogens, or monoclonal antibodies with the antigen specific T-cell receptor complex.
Thomas A. Waldmann   +6 more
openaire   +1 more source

Interleukin 2/interleukin 2 receptor system in type 1 diabetes

Diabetes Research and Clinical Practice, 1989
There is increasing evidence that cellular immune abnormalities are involved in the pathogenesis of type 1 diabetes mellitus. The non-obese diabetic (NOD) mouse, a model of human type 1 diabetes, develops mononuclear cell infiltration of its pancreatic islets (insulitis), leading to /3 cell destruction and overt diabetes [l]. In recent studies, most of
N, Hatamori   +4 more
openaire   +2 more sources

Interleukin-2, anti-interleukin-2 receptor antibody, and activation of macrophages

Cellular Immunology, 1990
Macrophages treated with IFN-gamma and IL-2 before exposure to parasites develop the ability to resist infection with amastigotes of Leishmania major. In this cooperative interaction of cytokines, IL-2 can be replaced with any of several mAb directed against the beta chain of the IL-2 receptor, but not by antibodies to a number of other cell receptors ...
M, Belosevic, C A, Nacy
openaire   +2 more sources

Home - About - Disclaimer - Privacy